{
  "id": 571013,
  "title": "Sionna Therapeutics stock plunged 92% after its cystic fibrosis drug flopped in a mid-stage trial",
  "url": "https://urgent.news/2026/08/11/sionna-therapeutics-stock-plunged-92-after-its-cystic-fibrosis-drug",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-11T13:20:37.000Z",
  "source": {
    "name": "Quartz",
    "slug": "quartz",
    "url": "https://qz.com/sionna-therapeutics-stock-cystic-fibrosis-drug-trial-failure-081126"
  },
  "original_language": "en",
  "account": null,
  "summary": "The biotech said it will not advance SION-719 as an add-on therapy after the drug missed its key endpoint in a Phase 2a study",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}